Zepbound and Semaglutide in Denver, Aurora and Boulder: Costs, Coverage and Options

If you live in the Denver area and are looking into Zepbound or semaglutide, the price depends mostly on your coverage. Here is what they cost, how a sleep apnea diagnosis can change what Colorado plans pay, and the studies enrolling in Aurora.

Author image

Written by Valerii Vasilevskyi, MD, PhD

Published

Colorado has the lowest adult obesity rate of any state, 25.7 percent in 2025 according to CDC survey data, but that is still about 1 in 4 adults. In the Denver area, questions about Zepbound usually come down to two things: what it costs, and whether a sleep apnea diagnosis changes who pays. It can. Zepbound is approved both for weight management and for moderate to severe obstructive sleep apnea in adults with obesity, and employer plans, Health First Colorado and Medicare treat those two uses differently.

This guide explains the two approvals, what Zepbound costs without insurance and how semaglutide compares, how coverage works in Colorado for weight loss and for sleep apnea, and the studies enrolling in Aurora and across the metro.

Sleep apnea and a BMI of 27 or higher?

A study at a site in Aurora is testing eloralintide, an investigational once-weekly injection, in adults with moderate to severe obstructive sleep apnea. You can take part whether or not you use CPAP. People with diabetes, or who took a weight loss medicine in the past 90 days, are not eligible.

One medicine, two approvals

Zepbound (tirzepatide) is a once-weekly injection. It was approved for weight management in November 2023 and for moderate to severe obstructive sleep apnea in adults with obesity in December 2024. Mounjaro contains the same medicine at the same doses but is approved for type 2 diabetes, so insurers usually pay for it only with that diagnosis.

The two Zepbound approvals have different rules. For weight management, it is approved for a BMI of 30 or higher, or 27 or higher with a weight-related condition. For sleep apnea, it requires a sleep study showing moderate to severe apnea and obesity, which in practice means a BMI of 30 or higher.

Semaglutide is the other main option: Wegovy for weight management, as an injection or a daily pill, and Ozempic for type 2 diabetes. Lilly also sells a daily GLP-1 pill, Foundayo, approved in April 2026; our Foundayo vs Zepbound guide compares it with the injection.

What Zepbound costs in Denver without insurance

Lilly sells Zepbound directly through LillyDirect, as single-dose vials or a KwikPen, at the same price in Colorado as everywhere else. As of November 2026, the 2.5 mg starting dose costs $299 a month and 5 mg costs $399. From 7.5 mg to 15 mg the price is $449 a month, but only if each refill is completed within 45 days of the last one; a late refill at those doses costs $499 to $699.

For comparison, Wegovy injections cost $349 a month through NovoCare Pharmacy, with two $199 starting fills for new patients through December 31, 2026, and the Wegovy pill and Foundayo start at $149 a month. A Denver or Aurora clinic may add a fee for visits or bundle everything into one price. Compounded tirzepatide sold by some clinics is not FDA-approved, and the FDA has said it cannot be marketed as the same as Zepbound.

Weight loss or sleep apnea: how coverage works in Colorado

Employer plans

If your plan excludes weight loss medicines, a sleep apnea diagnosis can change the answer. Many plans that do not pay for weight loss do cover Zepbound for diagnosed moderate to severe sleep apnea, usually with prior authorization that asks for your sleep study, your BMI and often proof that you tried CPAP. Ask your plan which route it uses before your prescriber submits anything.

Health First Colorado (Medicaid)

Health First Colorado does not cover Wegovy or Zepbound for weight loss alone. It does cover some GLP-1 medicines for type 2 diabetes, with prior authorization. For sleep apnea, it can cover Zepbound with prior authorization if you are 18 or older, have a BMI of 30 or higher and an AHI of 15 or more on a sleep study, and have tried CPAP for six months without success or cannot use it. A sleep specialist, pulmonologist, neurologist or ENT doctor needs to prescribe it or be consulted.

Medicare

Medicare's temporary GLP-1 Bridge, in place from July 1, 2026, through December 31, 2027, sets a $50 monthly price for Wegovy, the Zepbound KwikPen and Foundayo, but only when they are used for weight loss by people with Part D who meet its BMI rules. People with moderate to severe sleep apnea or type 2 diabetes are sent back to their regular Part D plan instead, at that plan's price. Part D plans are allowed to cover Zepbound for sleep apnea, since Medicare's exclusion applies to weight loss, but what you pay depends on your plan's formulary.

If sleep apnea is part of the picture

In the trials that led to the sleep apnea approval, 42 to 50 percent of people on Zepbound reached remission or mild apnea without symptoms after a year; the full results are in our guide to Zepbound for sleep apnea. Sleep doctors generally keep CPAP in place until a repeat sleep study shows it is no longer needed.

Article preview image

If CPAP has never worked for you, our guide to CPAP alternatives covers the other options.

CPAP Alternatives That Actually Work for Sleep Apnea

If your BMI is between 27 and 29.9, the sleep apnea approval does not cover you, even with severe apnea. Zepbound can still be prescribed for weight management, because sleep apnea counts as a weight-related condition, but many plans do not pay for that use. That is one of the groups the study below was built for.

Studies enrolling in the Denver area

Several studies near Denver test new weight loss and sleep apnea medicines. The study provides the medicine and the visits it requires, and many reimburse travel. For studies outside the metro, see all weight loss clinical trials by location.

Sleep apnea with a BMI of 27 or higher

A phase 3 study of eloralintide, an investigational once-weekly injection from Eli Lilly, is enrolling at a site in Aurora. Eloralintide works through amylin, a different hormone from the ones Zepbound and Wegovy target.

  • Who it is for: adults with confirmed moderate to severe obstructive sleep apnea (an AHI of 15 or more on a sleep study done as part of screening), a BMI of 27 or higher, a stable weight for the past 90 days, and at least one past attempt to lose weight by changing diet.
  • Two parts: one for people who cannot or prefer not to use CPAP, and one for people who have used CPAP for at least three months and plan to keep using it.
  • Who it is not for: people with any type of diabetes, a weight loss medicine in the past 90 days, past surgery for sleep apnea or weight loss, or a recent heart attack or stroke.
  • How it works: participants receive eloralintide or a placebo, assigned at random, for about 76 weeks.

See the eloralintide sleep apnea study.

Weight loss studies for a BMI of 27 or higher

A group of weight loss studies for adults with a BMI of 27 or higher, including people managing type 2 diabetes or sleep apnea, is enrolling in Denver, Aurora, Boulder and Colorado Springs. Check if you qualify for these weight loss studies.

If CPAP was too hard to use

Other studies near Denver are looking for adults with obstructive sleep apnea and a BMI of 27 or higher who stopped CPAP because they could not tolerate it. See these sleep apnea studies.

Type 2 diabetes

Studies on blood sugar and weight management are enrolling adults with type 2 diabetes who are not on insulin. See the type 2 diabetes studies, or browse everything on our Denver clinical trials page.

Your safety comes first, but no study is risk-free. Before you agree to anything, the study team walks you through the informed consent form, including whether you might receive a placebo; our guide to placebo-controlled trials explains why studies use one. An independent review board oversees the study, and you can leave at any time.

Common questions

How much does Zepbound cost in Denver without insurance? Through LillyDirect, Zepbound costs $299 a month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg to 15 mg with on-time refills, as of November 2026. The price is the same in Denver as elsewhere.

Is Zepbound covered for sleep apnea? Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. Many plans that exclude weight loss medicines cover it for this diagnosis, usually with prior authorization and a sleep study.

Does Medicare cover Zepbound for sleep apnea? Not through the $50 GLP-1 Bridge, which applies only to weight loss. For sleep apnea, coverage goes through your regular Part D plan, which is allowed to cover Zepbound for this diagnosis at the plan's own price.

Does Health First Colorado cover Zepbound or Wegovy? Not for weight loss alone. Health First Colorado covers some GLP-1 medicines for type 2 diabetes with prior authorization, and it can cover Zepbound for moderate to severe sleep apnea if your BMI is 30 or higher and CPAP has not worked.

What if I have sleep apnea but my BMI is under 30? The Zepbound sleep apnea approval does not cover a BMI under 30. With a BMI of 27 to 29.9, Zepbound can still be prescribed for weight management, though many plans do not cover it. A study of eloralintide in Aurora is enrolling adults with moderate to severe sleep apnea and a BMI of 27 or higher.

Do I still need CPAP if I take Zepbound? The approval does not say to stop CPAP. In the trials, people already using CPAP kept using it, and sleep doctors generally keep it in place until a repeat sleep study shows it is no longer needed.

Do sleep apnea and weight loss study participants get paid? Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.

Share this article on social media: